Ocugen, Inc. (NASDAQ: OCGN) has reached a significant milestone in the development of its gene-agnostic therapy, OCU400, as the European Commission has delivered a positive opinion designating it ...
I've compiled this list of the ten must-have tools for designers that they should have in their toolkit. Follow the Inkbot Design Blog for more tips! Designers today have access to an incredible array ...
Following another weak quarter, we find BP strongly underperformed both its European and US peers since 2021, with Q4 earnings the lowest since late 2020. Yet, BP remains the primary value ...
CyberArk (NASDAQ: CYBR), the global leader in identity security, today announced Identity Bridge, an endpoint identity security capability that will support identity and privilege sprawl reduction on ...